Metropolitan Life Insurance CO Vera Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$14.91 - $49.14 $2,191 - $7,223	-147 Reduced 6.47%	2,125 $91,000
Q3 2023 Nov 14, 2023	BUY	$13.71 - $19.64 $5,264 - $7,541	384 Added 20.34%	2,272 $31,000
Q2 2023 Aug 10, 2023	BUY	$6.11 - $17.83 $3,421 - $9,984	560 Added 42.17%	1,888 $30,000
Q1 2023 May 15, 2023	BUY	$5.41 - $18.3 $1,552 - $5,252	287 Added 27.57%	1,328 $10,000
Q4 2022 Jun 14, 2023	SELL	$15.74 - $22.19 $4,517 - $6,368	-287 Reduced 21.61%	1,041 $20.1 Million
Q3 2022 Jun 14, 2023	SELL	$13.27 - $22.31 $3,808 - $6,402	-287 Reduced 21.61%	1,041 $22.2 Million
Q2 2022 Jun 20, 2023	SELL	$12.82 - $23.4 $3,679 - $6,715	-287 Reduced 21.61%	1,041 $14,000
Q1 2022 Jun 20, 2023	SELL	$17.8 - $28.06 $5,108 - $8,053	-287 Reduced 21.61%	1,041 $24,000
Q1 2022 May 12, 2022	BUY	$17.8 - $28.06 $18,529 - $29,210	1,041 New	1,041 $24,000

185

55.6M

134K

156K

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.03B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.